---

Browse the article contributions of Maximilian Strobl below or browse the full blog here.

Behind the newsletter cover

Showcasing the creativity of the MathOnco community

Written by Maximilian Strobl on September 16, 2022

Adaptive dose personalization

What's first, what's second?

Written by Jeffrey West, Maximilian Strobl on March 02, 2021

K for carrying capacity?

A brief discussion of why we shouldn't forget about death in the logistic growth equation

Written by Maximilian Strobl on April 04, 2020

---

Recordings from the MathOnco25 conference:

Bridging the gap: What pre-clinical experiments can teach us about math model-guided treatment scheduling

"Cancers are complex and evolving diseases. To tackle this complexity there has been growing interest in developing “digital twins” –..."

Presented by Maximilian Strobl, at MathOnco25 on October 28, 2025

---

Artworks by Maximilian Strobl ^M :

Each week, we feature cover artwork submitted by mathematical oncology researchers around the world. Browse the contributions of Maximilian Strobl below. Click to expand each cover, or browse the full collection here.

Issue 354

"38 covers –that is our tally for 2025! Ranging fromdepictions ofspatial point patterns (#324), negative spaces between Kaplan-Meier curves (#329),..."

View this issue on Substack
View full size

Issue 346

"High-grade serous ovarian cancer (HGSOC) remains a challenging disease to treat due to high recurrence rates, acquired resistance, and cumulative..."

View this issue on Substack
View full size

Issue 331

"This week's cover showcases some of the exciting Mathonco representation at the AACR Annual Meeting 2025, which was held in..."

View this issue on Substack
View full size

Issue 327

"Last week we held our yearly team meeting. This is a time for us to reflect on the state of..."

View this issue on Substack
View full size

Issue 320

"Metastasis remains the leading cause of cancer-related mortality, driven by the complex interplay between immune cells and micrometastases. Multiscale mathematical..."

View this issue on Substack
View full size

Issue 318

"In the midst of a grey and cold January arctic vortex, I thought I'd warm things up with a look..."

View this issue on Substack
View full size

Issue 314

"The advent of targeted therapy with Tyrosine Kinase Inhibitors (TKIs) has changed the paradigm for Chronic Myeloid Leukemia, with most..."

View this issue on Substack
View full size

Issue 303

"PARP inhibitors have transformed ovarian cancer care, but many patients require dose adjustments or drug holidays due to toxicity. We..."

View this issue on Substack
View full size

Issue 296

"This week, I thought I would do a little behind the scenes about what I enjoy doing outside of the..."

View this issue on Substack
View full size

Issue 275

"Cancer research has traditionally focused on developing new agents, but an underexplored question is that of the dose and frequency..."

View this issue on Substack
View full size

Issue 264

"Quantifying and characterizing metastases is tough due to the dispersal of cancer cells across multiple sites and the paucity of..."

View this issue on Substack
View full size

Issue 232

"Next week IMO will run its 10th annual workshop. This workshop is designed to motivate and facilitate a hands-on modeling..."

View this issue on Substack
View full size

Issue 227

"It all began with one of those fateful lunchtime conversations. “Wouldn’t it be cool if the mathonco newsletter had cover..."

View this issue on Substack
View full size

Issue 220

"Heterogeneity is a landmark of glioblastoma tumors. How such heterogeneity is set up remains unknown. We recently discovered the existence..."

View this issue on Substack
View full size

Issue 219

"The MathOnco community continues to grow with new people and groups joining every day. In order to make these incredible,..."

View this issue on Substack
View full size

Issue 218

"Have you ever wanted to visualize a histogram or density from counts of (x,y) pairs? Say if you wanted take..."

View this issue on Substack
View full size

Issue 217

"By enabling us to better map out the spatial distribution of multiple cell types at the same time, emerging multiplexed..."

View this issue on Substack
View full size

Issue 208

"Adaptive therapy aims to leverage competition between drug-sensitive and resistant cells by adjusting treatment to maintain the tumor at a..."

View this issue on Substack
View full size

Issue 204

"In our recent paper, we examined the tumor-immune eco-evolutionary dynamics from pre-cancer to carcinoma in colorectal cancer using a combination..."

View this issue on Substack
View full size

Issue 171

"The letters of the text "This week in MathOnco" provide a chemotactic signal for migrating cells (in white). Cells within..."

View this issue on Substack
View full size

Issue 169

"To mix things, I thought I would tell you a little about myself today. I’m very interested in adaptive cancer..."

View this issue on Substack
View full size